CANDEL THERAPEUTICS
CADL Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-03-19
2025-03-20
TAK PAUL PETER
Chief Executive Officer
S - Sale
Common Stock
-400
$9.00
-3,600
1
$246.51M
2025-03-18
2025-03-20
BARONE FRANCESCA
Chief Scientific Officer
M - Exercise
Common Stock
18,000
$2.00
36,000
1
$246.51M
2025-03-18
2025-03-20
NICHOLS WILLIAM GARRETT
Chief Medical Officer
M - Exercise
Stock Option (Right to Buy)
-18,489
$0.00
2
$246.51M
2025-03-18
2025-03-20
NICHOLS WILLIAM GARRETT
Chief Medical Officer
M - Exercise
Common Stock
18,489
$2.00
36,978
2
$246.51M
2025-03-18
2025-03-20
BARONE FRANCESCA
Chief Scientific Officer
S - Sale
Common Stock
-32,146
$9.00
-289K
1
$246.51M
2025-03-18
2025-03-20
NICHOLS WILLIAM GARRETT
Chief Medical Officer
S - Sale
Common Stock
-45,316
$9.00
-408K
1
$246.51M
2025-03-18
2025-03-20
TAK PAUL PETER
Chief Executive Officer
S - Sale
Common Stock
-25,772
$9.00
-232K
1
$246.51M
2025-03-18
2025-03-20
BARONE FRANCESCA
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-18,000
$0.00
1
$246.51M
2025-03-18
2025-03-20
BARONE FRANCESCA
Chief Scientific Officer
M - Exercise
Common Stock
18,000
$2.00
36,000
1
$246.51M
2025-03-18
2025-03-20
NICHOLS WILLIAM GARRETT
Chief Medical Officer
M - Exercise
Stock Option (Right to Buy)
-18,489
$0.00
2
$246.51M
2025-03-18
2025-03-20
NICHOLS WILLIAM GARRETT
Chief Medical Officer
M - Exercise
Common Stock
18,489
$2.00
36,978
2
$246.51M
2025-03-18
2025-03-20
BARONE FRANCESCA
Chief Scientific Officer
S - Sale
Common Stock
-32,146
$9.00
-289K
1
$246.51M
2025-03-18
2025-03-20
NICHOLS WILLIAM GARRETT
Chief Medical Officer
S - Sale
Common Stock
-45,316
$9.00
-408K
1
$246.51M
2025-03-18
2025-03-20
TAK PAUL PETER
Chief Executive Officer
S - Sale
Common Stock
-25,772
$9.00
-232K
1
$246.51M
2025-03-18
2025-03-20
BARONE FRANCESCA
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-18,000
$0.00
1
$246.51M
2025-03-17
2025-03-20
TYAGARAJAN SESHU
Chief Technology Officer
M - Exercise
Common Stock
20,000
$1.00
20,000
1
$246.51M
2025-03-17
2025-03-20
TYAGARAJAN SESHU
Chief Technology Officer
M - Exercise
Stock Option (Right to Buy)
-20,000
$0.00
1
$246.51M
2025-03-17
2025-03-20
TYAGARAJAN SESHU
Chief Technology Officer
S - Sale
Common Stock
-31,278
$9.00
-282K
1
$246.51M
2025-03-17
2025-03-19
TYAGARAJAN SESHU
Chief Technology Officer
M - Exercise
Stock Option (Right to Buy)
-20,000
$0.00
1
$246.51M
2025-03-17
2025-03-19
SCHOCH CHARLES
Interim Chief Financial Office...
S - Sale
Common Stock
-5,000
$9.00
-45,000
1
$246.51M
2025-03-17
2025-03-19
TYAGARAJAN SESHU
Chief Technology Officer
S - Sale
Common Stock
-31,278
$9.00
-282K
1
$246.51M
2025-02-12
2025-02-14
BARONE FRANCESCA
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
115K
$0.00
1
$246.51M
2025-02-12
2025-02-14
NICHOLS WILLIAM GARRETT
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
107K
$0.00
1
$246.51M
2025-02-12
2025-02-14
SCHOCH CHARLES
Interim Chief Financial Office...
A - Grant
Stock Option (Right to Buy)
83,000
$0.00
1
$246.51M
2025-02-12
2025-02-14
TAK PAUL PETER
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
525K
$0.00
1
$246.51M
2025-02-12
2025-02-14
TYAGARAJAN SESHU
Chief Technology Officer
A - Grant
Stock Option (Right to Buy)
65,000
$0.00
1
$246.51M
2025-01-15
2025-01-17
BARONE FRANCESCA
Chief Scientific Officer
S - Sale
Common Stock
-13,534
$7.00
-94,738
1
$246.51M
2025-01-15
2025-01-17
NICHOLS WILLIAM GARRETT
Chief Medical Officer
S - Sale
Common Stock
-10,428
$7.00
-72,996
1
$246.51M
2025-01-15
2025-01-17
SCHOCH CHARLES
Interim Chief Financial Office...
S - Sale
Common Stock
-9,511
$7.00
-66,577
1
$246.51M
2025-01-15
2025-01-17
TAK PAUL PETER
Chief Executive Officer
S - Sale
Common Stock
-21,704
$7.00
-152K
1
$246.51M
2025-01-15
2025-01-17
TYAGARAJAN SESHU
Chief Technology Officer
S - Sale
Common Stock
-14,322
$7.00
-100K
1
$246.51M
2025-01-15
2025-01-15
BARONE FRANCESCA
Chief Scientific Officer
S - Sale
-12,452
$8.00
-99,616
1
$246.51M
2025-01-15
2025-01-15
NICHOLS WILLIAM GARRETT
Chief Medical Officer
S - Sale
-9,564
$8.00
-76,512
1
$246.51M
2025-01-15
2025-01-15
SCHOCH CHARLES
Interim Chief Financial Office...
S - Sale
-8,751
$8.00
-70,008
1
$246.51M
2025-01-08
2025-01-10
TAK PAUL PETER
Chief Executive Officer
S - Sale
Common Stock
-21,172
$8.00
-169K
1
$246.51M
2025-01-08
2025-01-10
BARONE FRANCESCA
Chief Scientific Officer
S - Sale
Common Stock
-13,673
$8.00
-109K
1
$246.51M
2025-01-08
2025-01-10
NICHOLS WILLIAM GARRETT
Chief Medical Officer
S - Sale
Common Stock
-10,799
$8.00
-86,392
1
$246.51M
2025-01-08
2025-01-10
SCHOCH CHARLES
Interim Chief Financial Office...
S - Sale
Common Stock
-9,971
$8.00
-79,768
1
$246.51M
2025-01-08
2025-01-10
TYAGARAJAN SESHU
Chief Technology Officer
S - Sale
Common Stock
-14,545
$8.00
-116K
1
$246.51M
2025-01-08
2025-01-08
NICHOLS WILLIAM GARRETT
Chief Medical Officer
S - Sale
-10,614
$8.00
-84,912
1
$246.51M
2025-01-08
2025-01-08
SCHOCH CHARLES
Interim Chief Financial Office...
S - Sale
-9,801
$8.00
-78,408
1
$246.51M
2024-11-29
2024-12-03
TYAGARAJAN SESHU
Chief Technology Officer
S - Sale
Common Stock
-20,392
$5.00
-102K
1
$246.51M
2024-11-29
2024-12-03
TAK PAUL PETER
Chief Executive Officer
S - Sale
Common Stock
-48,847
$5.00
-244K
1
$246.51M
2024-11-29
2024-12-03
BARONE FRANCESCA
Chief Scientific Officer
S - Sale
Common Stock
-22,081
$5.00
-110K
1
$246.51M
2024-11-29
2024-12-03
NICHOLS WILLIAM GARRETT
Chief Medical Officer
S - Sale
Common Stock
-13,935
$5.00
-69,675
1
$246.51M
2024-11-29
2024-11-29
NICHOLS WILLIAM GARRETT
Chief Medical Officer
S - Sale
-12,675
$5.00
-63,375
1
$246.51M
2024-11-29
2024-11-29
TYAGARAJAN SESHU
Chief Technology Officer
S - Sale
-18,548
$5.00
-92,740
1
$246.51M
2024-11-21
2024-11-21
TAK PAUL PETER
Chief Executive Officer
M - Exercise
Stock Option (Right to Buy)
-12,900
$0.00
1
$246.51M
2024-11-21
2024-11-21
TAK PAUL PETER
Chief Executive Officer
M - Exercise
Common Stock
12,900
$2.00
25,800
1
$246.51M
2024-07-17
2024-07-19
BARONE FRANCESCA
Chief Scientific Officer
S - Sale
Common Stock
-14,051
$6.00
-84,306
1
$246.51M
2024-07-17
2024-07-19
NICHOLS WILLIAM GARRETT
Chief Medical Officer
S - Sale
Common Stock
-10,875
$6.00
-65,250
1
$246.51M
2024-07-17
2024-07-19
SCHOCH CHARLES
Interim Chief Financial Office...
S - Sale
Common Stock
-9,884
$6.00
-59,304
1
$246.51M
2024-07-17
2024-07-19
TAK PAUL PETER
Chief Executive Officer
S - Sale
Common Stock
-22,528
$6.00
-135K
1
$246.51M
2024-07-17
2024-07-19
TYAGARAJAN SESHU
Chief Technology Officer
S - Sale
Common Stock
-14,851
$6.00
-89,106
1
$246.51M
2024-07-17
2024-07-17
SCHOCH CHARLES
Interim Chief Financial Office...
S - Sale
-8,761
$7.00
-61,327
1
$246.51M
2024-07-17
2024-07-17
BARONE FRANCESCA
Chief Scientific Officer
S - Sale
-12,455
$7.00
-87,185
1
$246.51M
2024-07-17
2024-07-17
NICHOLS WILLIAM GARRETT
Chief Medical Officer
S - Sale
-9,640
$7.00
-67,480
1
$246.51M
2024-07-17
2024-07-17
TYAGARAJAN SESHU
Chief Technology Officer
S - Sale
-13,164
$7.00
-92,148
1
$246.51M
2024-07-11
2024-07-15
NICHOLS WILLIAM GARRETT
Chief Medical Officer
S - Sale
Common Stock
-9,769
$6.00
-58,614
1
$246.51M
2024-07-11
2024-07-15
SCHOCH CHARLES
Interim Chief Financial Office...
S - Sale
Common Stock
-8,897
$6.00
-53,382
1
$246.51M
2024-07-11
2024-07-15
TAK PAUL PETER
Chief Executive Officer
S - Sale
Common Stock
-20,293
$6.00
-122K
1
$246.51M
2024-07-11
2024-07-15
TYAGARAJAN SESHU
Chief Technology Officer
S - Sale
Common Stock
-13,330
$6.00
-79,980
1
$246.51M
2024-07-11
2024-07-15
BARONE FRANCESCA
Chief Scientific Officer
S - Sale
Common Stock
-12,645
$6.00
-75,870
1
$246.51M
2024-07-11
2024-07-11
BARONE FRANCESCA
Chief Scientific Officer
S - Sale
-12,443
$6.00
-74,658
1
$246.51M
2024-07-11
2024-07-11
NICHOLS WILLIAM GARRETT
Chief Medical Officer
S - Sale
-9,613
$6.00
-57,678
1
$246.51M
2024-07-11
2024-07-11
SCHOCH CHARLES
Interim Chief Financial Office...
S - Sale
-8,754
$6.00
-52,524
1
$246.51M
2024-07-11
2024-07-11
TYAGARAJAN SESHU
Chief Technology Officer
S - Sale
-13,117
$6.00
-78,702
1
$246.51M
2023-11-28
2023-11-30
TYAGARAJAN SESHU
Chief Technology Officer
F - Tax
Common Stock
-17,328
$1.00
-17,328
1
$246.51M
2023-11-28
2023-11-30
AMELLO JASON
Chief Financial Officer
F - Tax
Common Stock
-20,153
$1.00
-20,153
1
$246.51M
2023-11-28
2023-11-30
BARONE FRANCESCA
Chief Scientific Officer
F - Tax
Common Stock
-19,748
$1.00
-19,748
1
$246.51M
2023-11-28
2023-11-30
NICHOLS WILLIAM GARRETT
Chief Medical Officer
F - Tax
Common Stock
-12,175
$1.00
-12,175
1
$246.51M
2023-11-28
2023-11-30
TAK PAUL PETER
Chief Executive Officer
F - Tax
Common Stock
-43,443
$1.00
-43,443
1
$246.51M
2023-11-26
2023-11-28
TAK PAUL PETER
Chief Executive Officer
A - Grant
Common Stock
180K
$0.00
1
$246.51M
2023-11-26
2023-11-28
TYAGARAJAN SESHU
Chief Technology Officer
A - Grant
Common Stock
105K
$0.00
1
$246.51M
2023-11-26
2023-11-28
BARONE FRANCESCA
Chief Scientific Officer
A - Grant
Common Stock
113K
$0.00
1
$246.51M
2023-11-26
2023-11-28
NICHOLS WILLIAM GARRETT
Chief Medical Officer
A - Grant
Common Stock
88,822
$0.00
1
$246.51M
2023-06-28
2023-06-29
AGUILAR-CORDOVA ESTUARDO
A - Grant
Stock Option (Right to Buy)
14,240
$0.00
1
$246.51M
2023-04-28
2023-05-02
AMELLO JASON
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
90,000
$0.00
1
$246.51M
2023-04-28
2023-05-02
BARONE FRANCESCA
Chief Scientific Officer
A - Grant
Stock Option (Right to Biuy)
90,000
$0.00
1
$246.51M
2023-04-28
2023-05-02
NICHOLS WILLIAM GARRETT
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
45,000
$0.00
1
$246.51M
2023-04-28
2023-05-02
TYAGARAJAN SESHU
Chief Technology Officer
A - Grant
Stock Option (Right to Buy)
90,000
$0.00
1
$246.51M
2023-04-28
2023-05-02
TAK PAUL PETER
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
180K
$0.00
1
$246.51M
2022-12-09
2022-12-12
AMELLO JASON
Chief Financial Officer
P - Purchase
Common Stock
2,468
$2.00
4,936
1
$246.51M
2022-12-09
2022-12-12
TAK PAUL PETER
Chief Executive Officer
P - Purchase
Common Stock
12,935
$2.00
25,870
1
$246.51M
2022-12-09
2022-12-12
TYAGARAJAN SESHU
Chief Technology Officer
P - Purchase
Common Stock
10,358
$2.00
20,716
1
$246.51M
2022-12-08
2022-12-12
TYAGARAJAN SESHU
Chief Technology Officer
P - Purchase
Common Stock
3,000
$2.00
6,000
1
$246.51M
2022-12-08
2022-12-12
TAK PAUL PETER
Chief Executive Officer
P - Purchase
Common Stock
3,050
$2.00
6,100
1
$246.51M
2022-12-08
2022-12-12
AMELLO JASON
Chief Financial Officer
P - Purchase
Common Stock
3,100
$2.00
6,200
1
$246.51M
2022-12-08
2022-12-12
BARONE FRANCESCA
Chief Scientific Officer
P - Purchase
Common Stock
1,238
$2.00
2,476
1
$246.51M
2022-11-28
2022-11-30
AMELLO JASON
Chief Financial Officer
A - Grant
Common Stock
90,877
$0.00
1
$246.51M
2022-11-28
2022-11-30
BARONE FRANCESCA
Chief Scientific Officer
A - Grant
Common Stock
90,877
$0.00
1
$246.51M
2022-11-28
2022-11-30
NICHOLS WILLIAM GARRETT
Chief Medical Officer
A - Grant
Common Stock
58,479
$0.00
1
$246.51M
2022-11-28
2022-11-30
TAK PAUL PETER
Chief Executive Officer
A - Grant
Common Stock
196K
$0.00
1
$246.51M
2022-11-28
2022-11-30
TYAGARAJAN SESHU
Exhibit 24 - Power of Attorney...
A - Grant
Common Stock
73,684
$0.00
1
$246.51M
2022-10-13
2022-10-17
AGUILAR-CORDOVA ESTUARDO
A - Grant
Stock Option (Right to Buy)
14,240
$0.00
1
$246.51M
2022-09-21
2022-09-23
AMELLO JASON
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
230K
$0.00
1
$246.51M
2022-09-12
2022-09-14
NICHOLS WILLIAM GARRETT
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
200K
$0.00
1
$246.51M
2022-05-06
2022-05-10
AGUILAR-CORDOVA ESTUARDO
M - Exercise
Stock Option (Right to Buy)
-135K
$0.00
3
$246.51M
2022-04-14
2022-04-15
TYAGARAJAN SESHU
Chief Technical and Developmen...
A - Grant
Stock Option (Right to Buy)
120K
$0.00
1
$246.51M
2022-04-11
2022-04-12
STEWART SUSAN
Chief Regulatory Officer
A - Grant
Stock Option (Right to Buy)
20,000
$0.00
1
$246.51M
2022-02-28
2022-03-01
TAK PAUL PETER
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
330K
$0.00
1
$246.51M
2022-02-28
2022-03-01
CANEPA JOHN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
110K
$0.00
1
$246.51M
2022-02-28
2022-03-01
BARONE FRANCESCA
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
110K
$0.00
1
$246.51M
2022-02-03
2022-02-07
BARONE FRANCESCA
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
40,000
$0.00
1
$246.51M
2021-07-29
2021-08-02
AGUILAR LAURA
Chief Medical Officer
C - Conversion
Series B Preferred Stock
-138K
$0.00
1
$246.51M
2021-07-29
2021-08-02
AGUILAR-CORDOVA ESTUARDO
Chief Scientific Officer
C - Conversion
Common Stock
162K
1
$246.51M
2021-07-29
2021-08-02
MARTELL CHRISTOPHER
C - Conversion
Series B Preferred Stock
-697K
$0.00
1
$246.51M
2021-07-29
2021-08-02
CAFFO NATHAN
Chief Business Officer
P - Purchase
Common Stock
6,000
$8.00
48,000
1
$246.51M
2021-07-29
2021-08-02
CANEPA JOHN
Chief Financial Officer
P - Purchase
Common Stock
10,125
$8.00
81,000
1
$246.51M
2021-07-29
2021-08-02
TAK PAUL PETER
Chief Executive Officer
P - Purchase
Common Stock
25,000
$8.00
200K
1
$246.51M
2021-07-29
2021-08-02
AGUILAR-CORDOVA ESTUARDO
Chief Scientific Officer
C - Conversion
Series B Preferred Stock
-399K
$0.00
1
$246.51M